Skip to content

13F-HR filed by Integral Health Asset Management, LLC

Integral Health Asset Management, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 57 holding rows worth $336,207,000.

Accession
0001420506-21-000317
Filed
2021-02-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2020

A holdings report, 57 entries on the cover page, a total value of $336,207,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $336,207,000 with VALUE read as thousands by filing date, 13F file number 028-19946. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SAGE THERAPEUTICS INC78667J108COM195,000$16,869,000thousands by filing date
ACADIA HEALTHCARE COMPANY INC COM00404A109Stock315,000$15,832,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW200,000$15,366,000thousands by filing date
NEVRO CORP64157F103COM88,000$15,233,000thousands by filing date
LHC GROUP50187A107COM68,000$14,506,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM53,000$13,243,000thousands by filing date
CHEMOCENTRYX INC16383L106COM180,000$11,146,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW525,000$10,910,000thousands by filing date
ENVISTA HOLDINGS CORPORATION29415F104COM320,000$10,794,000thousands by filing date
MCKESSON CORP COM58155Q103Stock55,000$9,566,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM85,000$9,533,000thousands by filing date
REVVITY INC714046109COM65,000$9,328,000thousands by filing date
Elevance Health, Inc.036752103COM28,000$8,991,000thousands by filing date
Abbott Laboratories002824100COM80,000$8,759,000thousands by filing date
Eli Lilly and Company532457108COM50,000$8,442,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS72,500$8,367,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM37,000$8,127,000thousands by filing date
BECTON DICKINSON & CO075887109COM32,000$8,007,000thousands by filing date
AbbVie,Inc.00287Y109COM70,000$7,501,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM85,000$7,454,000thousands by filing date
CENCORA INC COM03073E105Stock70,000$6,843,000thousands by filing date
CVS Health Corporation126650100COM100,000$6,830,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A50,000$6,181,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock70,000$5,788,000thousands by filing date
AVANTOR INC COM05352A100Stock200,000$5,630,000thousands by filing date
Johnson & Johnson478160104COM35,000$5,508,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock57,500$4,816,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock35,000$4,511,000thousands by filing date
NATERA INC COM632307104Stock45,000$4,478,000thousands by filing date
Medtronic PlcG5960L103COM35,000$4,100,000thousands by filing date
ZAI LAB LTD ADR98887Q104ADR30,000$4,060,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM50,000$3,837,000thousands by filing date
SHOCKWAVE MED INC82489T104COM35,000$3,630,000thousands by filing date
PENNANT GROUP INC70805E109COM60,000$3,484,000thousands by filing date
HCA Healthcare Inc40412C101COM20,000$3,289,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM60,000$3,264,000thousands by filing date
GLOBUS MED INC CL A379577208Stock50,000$3,261,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM75,000$3,250,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock95,000$3,103,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM200,000$2,702,000thousands by filing date
ALECTOR INC014442107COMMON STOCK165,000$2,496,000thousands by filing date
BIOGEN INC COM09062X103Stock10,000$2,449,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A135,000$2,385,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM85,000$2,193,000thousands by filing date
MACROGENICS INC556099109COM90,000$2,057,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock15,000$1,950,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM30,100$1,837,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK47,500$1,812,000thousands by filing date
EHEALTH INC28238P109COM25,000$1,765,000thousands by filing date
PROGYNY INC COM74340E103Stock40,000$1,696,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock50,000$1,665,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM100,000$1,548,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO50,000$1,381,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM15,000$1,286,000thousands by filing date
PRECISION BIOSCIENCES INC74019P108COM140,000$1,168,000thousands by filing date
LEXICON PHARMACEUTICALS INC528872302COMMON STOCK300,000$1,026,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK30,000$954,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-21-000317this filing2021-02-16acceptance time not in the bulk data set